Imaging features of toxicities associated with immune checkpoint inhibitors
The past decade has witnessed a change in landscape of cancer management with the advent of precision oncology. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and have played an important role in improving patient survival. While the patients are living longer, treatment wi...
Main Authors: | Babina Gosangi, Lacey McIntosh, Abhishek Keraliya, David Victor Kumar Irugu, Akshay Baheti, Ashish Khandelwal, Richard Thomas, Marta Braschi-Amirfarzan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | European Journal of Radiology Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352047722000417 |
Similar Items
-
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center
by: Malek Shatila, et al.
Published: (2024-01-01) -
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study
by: Chloe Ahryung Lim, et al.
Published: (2023-12-01) -
Importance of tumor subtypes in cancer imaging
by: Ali Khader, et al.
Published: (2022-01-01) -
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Retrospective Comparison Focusing on Pulmonary Toxicity
by: Romana Wass, et al.
Published: (2022-06-01) -
Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus
by: Hung-Hui Wei, et al.
Published: (2024-01-01)